MQS Management LLC Buys Shares of 906 Molina Healthcare, Inc. (NYSE:MOH)

MQS Management LLC purchased a new position in shares of Molina Healthcare, Inc. (NYSE:MOH) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 906 shares of the company’s stock, valued at approximately $269,000.

Several other institutional investors and hedge funds also recently made changes to their positions in MOH. XTX Topco Ltd grew its holdings in Molina Healthcare by 176.2% during the 2nd quarter. XTX Topco Ltd now owns 1,823 shares of the company’s stock worth $542,000 after acquiring an additional 1,163 shares during the last quarter. Seven Eight Capital LP lifted its holdings in shares of Molina Healthcare by 203.4% during the second quarter. Seven Eight Capital LP now owns 3,808 shares of the company’s stock worth $1,132,000 after purchasing an additional 2,553 shares during the period. Hsbc Holdings PLC lifted its holdings in shares of Molina Healthcare by 14.8% during the second quarter. Hsbc Holdings PLC now owns 113,259 shares of the company’s stock worth $33,726,000 after purchasing an additional 14,563 shares during the period. Amalgamated Bank grew its stake in shares of Molina Healthcare by 16.0% in the second quarter. Amalgamated Bank now owns 19,177 shares of the company’s stock worth $5,701,000 after purchasing an additional 2,647 shares during the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. increased its holdings in Molina Healthcare by 16.1% in the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 1,200 shares of the company’s stock valued at $357,000 after purchasing an additional 166 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the transaction, the director now owns 18,025 shares in the company, valued at $6,114,260.25. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the sale, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at approximately $3,282,583.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares of the company’s stock, valued at $6,114,260.25. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several brokerages have commented on MOH. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a report on Tuesday, September 10th. Robert W. Baird began coverage on shares of Molina Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $405.00 target price for the company. JPMorgan Chase & Co. reduced their price objective on shares of Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 10th. Stephens reissued an “equal weight” rating and set a $320.00 target price on shares of Molina Healthcare in a research note on Thursday, July 25th. Finally, Truist Financial cut their price target on shares of Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a research report on Monday, July 15th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $378.00.

Molina Healthcare Price Performance

MOH stock opened at $351.42 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57. The company’s 50-day moving average is $335.60 and its 200-day moving average is $343.44. The stock has a market capitalization of $20.59 billion, a PE ratio of 19.07, a price-to-earnings-growth ratio of 1.20 and a beta of 0.57. Molina Healthcare, Inc. has a 1 year low of $282.96 and a 1 year high of $423.92.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.73 by $0.13. The business had revenue of $9.88 billion for the quarter, compared to analyst estimates of $9.75 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The company’s quarterly revenue was up 18.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.65 earnings per share. Equities research analysts expect that Molina Healthcare, Inc. will post 23.5 EPS for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.